Testing effectiveness (Phase 2)Study completedNCT02468674
What this trial is testing
A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study
Who this might be right for
Sarcopenia
Novartis Pharmaceuticals 160